TAKEDA-C13006

Study Sponsor : Takeda

Study Title

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients With Moderate to Severe Ulcerative Colitis

Medicine or Vaccine (generic name)

vedolizumab

Sponsor Identification Number

C13006

Trial Registry Identification Number(#'s)

NCT00783718
2008-002782-32

Medical Condition

Ulcerative Colitis; Crohn's Disease

Phase

Phase 3

Link to study details on the Takeda Clinical Study Register

http://takedaclinicaltrials.com/browse/summary/C13006

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/show/NCT00783718

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-002782-32/ES

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2014